OPN was initially demonstrated to be an important potential biomarker mostly for the diagnosis of several cancers, such as non-small cell lung cancer, prostate, glioblastoma, malignant glioma [61,62,63]. Here, SPP1 is linked to non-small cell lung carcinoma.